Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
41.12
+1.13 (2.83%)
Jan 22, 2026, 3:54 PM EST - Market open
Liquidia Market Cap
Liquidia has a market cap or net worth of $3.58 billion as of January 22, 2026. Its market cap has increased by 243.86% in one year.
Market Cap
3.58B
Enterprise Value
3.57B
1-Year Change
243.86%
Ranking
Category
Stock Price
$41.12
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $3.58B, an increase of 2,031.92%. That is a compound annual growth rate of 50.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.48B | 15.93% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 3.79B |
| Corcept Therapeutics | 3.71B |
| NewAmsterdam Pharma Company | 3.67B |
| Centessa Pharmaceuticals | 3.35B |
| Alumis | 3.25B |
| Xenon Pharmaceuticals | 3.21B |
| Vera Therapeutics | 3.18B |
| Arcutis Biotherapeutics | 3.17B |